Skip to main content

Table 3 Geometric mean plasma levels* of E2, FSH, P4 and SHBG according to BMI among postmenopausal women not using HRT

From: Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer Postgenome Cohort – a cross-sectional analysis

  

E2 nmol/L

FSH IU/L

P4 nmol/L

SHBG nmol/L

 

n

95% CI

95% CI

95% CI

95% CI

BMI (kg/m2)

     

BMI < 25

137

0.07 (0.06–0.07)

76.7 (71.8–81.9)

0.87 (0.78–0.97)

51.8 (48.2–55.7)

25 ≤ BMI < 30

91

0.07 (0.06–0.07)

66.3 (61.2–71.9)

0.78 (0.68–0.89)

35.9 (32.8–39.2)

BMI ≥ 30

37

0.08 (0.07–0.09)

52.0 (45.8–59.1)

0.74 (0.61–0.91)

29.1 (25.3–33.5)

ANCOVA*

 

p = 0.08

p < 0.01

p = 0.25

p < 0.01

  1. * Adjusted for age. The covariates alcohol and parity did not contribute significantly to the model for any of the analyses, and was omitted.